Advertisement

European Cardiac Arrhythmia Society Statement on the cardiovascular events associated with the use or abuse of energy drinks

  • Samuel LévyEmail author
  • Luca Santini
  • Alessandro Capucci
  • Ali Oto
  • Maurizio Santomauro
  • Carla Riganti
  • Antonio Raviele
  • Riccardo Cappato
Reviews

Abstract

Energy drinks are increasingly used by young people and young athletes in order to improve their performance alone or in association of other substances, particularly alcohol. In recent years, a number of reports of reports have raised attention on the side-effects associated with the use or abuse of energy drinks particularly serious cardiovascular events. The European Cardiac Arrhythmia Society (ECAS) has undertaken a systematic and critical review of reported data on cardiovascular events including life-threatening arrhythmias with or without cardiac arrest and other cardiovascular events, and discussed in this review the possible causal effect of caffeine and other ingredients contained in energy drinks and the reported events. Twenty-two cardiovascular events were reported in association with the use or abuse of energy drinks. The European Cardiac Arrhythmia Society would like to draw attention on the possible cardiovascular complications that may occur with the consumption of these beverages and to emphasize the prevention measures to be taken particularly in the young population. Well-designed prospective studies are needed to clarify the possible role of energy drinks in inducing the cardiovascular events reported.

Keywords

ECAS statement Position paper Energy drinks Cardiac arrest Cardiovascular events Caffeine intoxication Taurine Glucoronolactone Guarana Ginseng Yerba mate 

Notes

References

  1. 1.
    Reissig CJ, Strain EC, Griffiths RR. Caffeinated energy drinks—a growing problem. Drug Alcohol Depend. 2009;99:1–10.CrossRefPubMedGoogle Scholar
  2. 2.
    Petit A, Karila L, Lejoyeux M. Abuse of energy drinks: does it pose a risk? Presse Med. 2015.  https://doi.org/10.1016/j.lpm.2014.07.029 (French).
  3. 3.
    Mangi MA, Rehman H, Rafique M, Illovsky M. Energy drinks and the risk of cardiovascular disease: a review of current literature. Cureus. 2017;9(6):e1322 (Open access).PubMedPubMedCentralGoogle Scholar
  4. 4.
    Malinauskas BM, Aeby VG, Overton RF, Carpenter-Aeby T, Barber-Heidal K. A survey of energy drink consumption patterns among college students. Nutr J. 2007;6:35.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Sanchis-Gomar F, Pareja-Galeano H, Cervellin G, Lippi G, Earnest C. P. Energy drink overconsumption in adolescents: implications for arrhythmias and other cardiovascular events. Can J Cardiol. 2015;31:572–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Bigard AX. Risks of energy drinks in the youths. Arch Pediatr. 2010;17:1625–31 (French).CrossRefPubMedGoogle Scholar
  7. 7.
    García A, Romero C, Arroyave C, Giraldo F, Sánchez L, Sánchez J. Acute effects of energy drinks in medical students. Eur J Nutr. 2017;56:2081–91.CrossRefPubMedGoogle Scholar
  8. 8.
    Wolk BJ, Ganetsky M, Babu KM. Toxicity of energy drinks. Curr Opin Pediatr. 2012;24:243–51.CrossRefPubMedGoogle Scholar
  9. 9.
    Seifert SM, Schaechter JL, Hershorin ER, Lipshultz SE. Health effects of energy drinks on children, adolescents, and young adults. Pediatrics. 2011;127:511–28.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Goldfarb M, Tellier C, Thanassoulis G. Review of published cases of adverse cardiovascular events after ingestion of energy drinks. Am J Cardiol. 2014;113:168–72.CrossRefPubMedGoogle Scholar
  11. 11.
    Ali F, Rehman H, Babayan Z, Stapleton D, Joshi DD. Energy drinks and their adverse health effects: a systematic review of the current evidence. Postgrad Med. 2015;127:308–2.CrossRefPubMedGoogle Scholar
  12. 12.
    Chrysant SG, Chrysant GS. Cardiovascular complications of high energy drinks: recent evidence. J Hum Hypertens. 2015;29:71–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Grasser EK, Miles-Chan JL, Charriere N, Loonam CR, Dulloo AG, Montani JP. Energy drinks and their impact on the cardiovascular system: potential mechanisms. Adv Nutr. 2016;7:950–60.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lippi G, Cervellin G, Sanchis-Gomar F. Energy drinks and myocardial ischemia: a review of case-reports. Cardiovasc Toxicol. 2016;16:207–12.CrossRefPubMedGoogle Scholar
  15. 15.
    Enriquez A, Frankel DS. Arrhythmogenic effects of energy drinks. J Cardiovasc Electrophysiol. 2017;28:711–7.CrossRefPubMedGoogle Scholar
  16. 16.
    Hampton T. Energy drinks pose worrisome risk to adolescents’ cardiovascular health. Circulation. 2016;134(14):1052–3.CrossRefPubMedGoogle Scholar
  17. 17.
    Heckman MA, Sherry K, De Mejia EG. Energy drinks: an assessment of their market size, consumer demographics, ingredient profile, functionality, and regulations in United States. Compr Rev Food Sci Food Saf. 2010;9:303–17.CrossRefGoogle Scholar
  18. 18.
    The DAWN Report: update on emergency department visits involving energy drinks: a continuing public health concern. Substance Abuse Services and Mental Health Administration, 2013. Available at: http://www.samhsa.gov/data/2k13/DAWN126/sr126-energydrinks-use.htm. Accessed on November 2018
  19. 19.
    Geller AI, Shehab N, Weidle NJ, Lovegrove MC, Wolpert BJ, Timbo BB, et al. Emergency department visits for adverse events related to dietary supplements. N Engl J Med. 2015;376:1531–9.CrossRefGoogle Scholar
  20. 20.
    Casuccio A, Bonanno V, Catalano R, Cracchiolo M, Giugno S, Sciuto V, et al. Knowledge, attitudes, and practices on energy drink consumption and side effects in a cohort of medical students. J Addict Dis. 2015;34:274–83.CrossRefPubMedGoogle Scholar
  21. 21.
    Higgins JP, Tuttle TD, Higgins CL. Energy beverages: content and safety. Mayo Clin Proc. 2010;85:1033–41.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Benowitz NL. Clinical pharmacology of caffeine. Annu Rev Med. 1990;41:277–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Arnaud MJ. Metabolism of caffeine and other components of coffee. In: Garattini S, editor. Caffeine, coffee and health. New York: Raven Press; 1993. p. 43–95.Google Scholar
  24. 24.
    Beyer LA, Hixon ML. Review of animal studies on the cardiovascular effects of caffeine. Food Chem Toxicol. 2018;118:566–71.CrossRefPubMedGoogle Scholar
  25. 25.
    Mehta A, Jain AC, Mehta MC, Billie M. Caffeine and cardiac arrhythmias. An experimental study in dogs with review of literature. Acta Cardiol. 1997;52:273–83.PubMedGoogle Scholar
  26. 26.
    Rashid A, Hines M, Scherlag BJ, Yamanashi WS, Lovallo W. The effects of caffeine on the inducibility of atrial fibrillation. J Electrocardiol. 2006;39:421–5.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Dobmeyer DJ, Stine RA, Leier CV, Greenberg R, Schaal SF. The arrhythmogenic effects of caffeine in human beings. N Engl J Med. 1983;7(308):814–6.CrossRefGoogle Scholar
  28. 28.
    Nawrot P, Jordan S, Eastwood J, et al. Effects of caffeine on human health. Food Addit Contam. 2003;20:1–30.CrossRefPubMedGoogle Scholar
  29. 29.
    Bøhn SK, Ward NC, Hodgson JM, Croft KD. Effects of tea and coffee on cardiovascular disease risk. Food Funct. 2012;3:575–91.CrossRefPubMedGoogle Scholar
  30. 30.
    Eilat-Adar S, Sinai T, Yosefy C, Henkin Y. Nutritional recommendations for cardiovascular disease prevention. Nutrients. 2013;5:3646–83.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Sutherland DJ, McPherson DD, Renton KW, Spencer CA, Montague TJ. The effect of caffeine on cardiac rate, rhythm, and ventricular repolarization. Analysis of 18 normal subjects and 18 patients with primary ventricular dysrhythmia. Chest. 1985;87:319–24.CrossRefPubMedGoogle Scholar
  32. 32.
    Myers MG, Harris L, Leenen FH, Grant DM. Caffeine as a possible cause of ventricular arrhythmias during the healing phase of acute myocardial infarction. Am J Cardiol. 1987;59:1024–8.CrossRefPubMedGoogle Scholar
  33. 33.
    Myers MG, Harris L. High dose caffeine and ventricular arrhythmias. Can J Cardiol. 1990;6(3):95–8.PubMedGoogle Scholar
  34. 34.
    Chelsky LB, Cutler JE, Griffith K, Kron J, McClelland JH, McAnulty JH. Caffeine and ventricular arrhythmias. An electrophysiological approach. JAMA. 1990;264(17):2236–40.CrossRefPubMedGoogle Scholar
  35. 35.
    Prineas RJ, Jacobs DR Jr, Crow RS, Blackburn H. Coffee, tea and VPB. J Chronic Dis. 1980;33(2):67–72.CrossRefPubMedGoogle Scholar
  36. 36.
    Zuchinali P, Ribeiro PA, Pimentel M, da Rosa PR, Zimerman LI, Rohde LE. Effect of caffeine on ventricular arrhythmia: a systematic review and meta-analysis of experimental and clinical studies. Europace. 2016;18:257–66.CrossRefPubMedGoogle Scholar
  37. 37.
    Lopez-Garcia E, van Dam RM, Willett WC, Rimm EB, Manson JE, Stampfer MJ, et al. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation. 2006;113:2045–53.CrossRefPubMedGoogle Scholar
  38. 38.
    Namdar M, Schepis T, Koepfli P, Gaemperli O, Siegrist PT, Grathwohl R, et al. Caffeine impairs myocardial blood flow response to physical exercise in patients with coronary artery disease as well as in age-matched controls. PLoS One. 2009;4(5):e5665.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Adamson RH. The acute lethal dose 50 (LD<sub>50</sub>) of caffeine in albino rats. Regul Toxicol Pharmacol. 2016;80:274–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Timbrell JA, Seabra V, Waterfield CJ. The in vivo and in vitro protective properties of taurine. Gen Pharmacol. 1995;26:453–62.CrossRefPubMedGoogle Scholar
  41. 41.
    Imagawa TF, Hirano I, Utsuki K, Horie M, Naka A, Matsumoto K, et al. Caffeine and taurine enhance endurance performance. Int J Sports Med. 2009;30:485–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Huxtable RJ. Physiological actions of taurine. Physiol Rev. 1992;72:101–63.CrossRefPubMedGoogle Scholar
  43. 43.
    Stipanuk MH. Role of liver in the regulation of body cysteine and taurine levels: a brief review. Neurochem Res. 2004;29:105–10.CrossRefPubMedGoogle Scholar
  44. 44.
    Shao A, Hathcock JN. Risk assessment for the amino acids taurine, L-glutamine and L-arginine. Regul Toxicol Pharmacol. 2008;50:376–99.CrossRefPubMedGoogle Scholar
  45. 45.
    Triebel S, Sproll C, Reusch H, et al. Rapid analysis of taurine in energy drinks using amino acid analyzer and Fourier transform infrared (FTIR) spectroscopy as basis for toxicological evaluation. Amino Acids. 2007;33:451–7.CrossRefPubMedGoogle Scholar
  46. 46.
    Finnegan D. The health effects of stimulant drinks. Br Nutr Found Nut Bull. 2003;28:147–55.CrossRefGoogle Scholar
  47. 47.
    Weckerle CS, Stutz MA, Baumann TW. Purine alkaloids in Paullinia. Phytochem. 2003;64:735–42.CrossRefGoogle Scholar
  48. 48.
    Espinola EB, Dias RF, Mattei R, Carlina EA. Pharmacological activity of guarana (Paullinia cupana Mart.). J Ethnopharmacol. 1997;55:223–9.CrossRefPubMedGoogle Scholar
  49. 49.
    Mattei R, Dias RF, Espinola EB, et al. Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidant activity in vitro. J Enthnopharmacol. 1998;60:111–6.CrossRefGoogle Scholar
  50. 50.
    Bempong DK, Houghton PJ. Dissolution and absorption of caffeine from guarana. J Pharm Pharmacol. 1992;44:769–71.CrossRefPubMedGoogle Scholar
  51. 51.
    Chinese Herbal Medicine: Materia Medica, Third Edition by Dan Bensky, Steven Clavey, Erich Stonger, and Andrew Gamble Eastland Press Seattle 2004.Google Scholar
  52. 52.
    Coon J, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf. 2002;25:323–44.CrossRefPubMedGoogle Scholar
  53. 53.
    Lu JM, Yao Q, Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Cur Vascul Pharmacol. 2009;7:293–302.CrossRefGoogle Scholar
  54. 54.
    Vogler BK, Pittler MH, Ernsy E. The efficacy of ginseng: a systematic review of randomized clinical trials. Eur J Clin Pharmacol. 1999;55:567–75.CrossRefPubMedGoogle Scholar
  55. 55.
    Heck CI, De Mejia EG. Yerba mate tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations. J Food Sci. 2007;72:138–51.CrossRefGoogle Scholar
  56. 56.
    Markowicz-Bastos DH, Moura de Oliveira D, Teixeira-Matsumoto RL, et al. Yerba mate: pharmacological properties, research and biotechnology. Med Aromat Plant Sci Biotech. 2007;1:37–46.Google Scholar
  57. 57.
    Rottlaender D, Motloch LJ, Reda S, Larbig R, Hoppe UC. Cardiac arrest due to long QT syndrome associated with excessive consumption of energy drinks. Int J Cardiol. 2012;158:e51–2.CrossRefPubMedGoogle Scholar
  58. 58.
    Cannon ME, Cooke CT, McCarthy JS. Caffeine-induced cardiac arrhythmia: an unrecognized danger of health food products. Med J Aust. 2001;174(10):520–1.CrossRefGoogle Scholar
  59. 59.
    Berger AJ, Alford K. Cardiac arrest in a young man following excess consumption of caffeinated “energy drinks”. Med J Aust. 2009;190:41–3.CrossRefGoogle Scholar
  60. 60.
    Jackman M, Wendling P, Friars D, Graham TE. Metabolic catecholamine, and endurance responses to caffeine during intense exercise. J Appl Phy Cureus. 2017;9(6):e1322.siol. 1996;81(4):1658–63.Google Scholar
  61. 61.
    Rutledge M, Witthed A, Khouzam RN. It took a RedBull to unmask Brugada syndrome. Int J Cardiol. 2012;161:e14–5.CrossRefPubMedGoogle Scholar
  62. 62.
    Avci S, Sarikaya R, Buyukcam F. Death of a young man after use of energy drink. Am J Emerg Med. 2013;31:1624.CrossRefPubMedGoogle Scholar
  63. 63.
    Ward AE, Lipshultz SE, Fisher SD. Energy-drink induced near fatal ventricular arrhythmia prevented by an intracardiac defibrillator decades after operative “repair” pf tetralogy of Fallot. Am J Cardiol. 2014;114:1124–5.CrossRefPubMedGoogle Scholar
  64. 64.
    Terlizzi R, Rocchi C, Serra M, Solieri L, Cortelli P. Reversible postural tachycardia syndrome due to inadvertent overuse of Red Bull. Clin Auton Res. 2008;18:221–3.CrossRefPubMedGoogle Scholar
  65. 65.
    Nagajothi N, Khraisat A, Velazquez-Cecena J-LE, et al. Energy drink-related supraventricular tachycardia. Am J Med. 2008;121:e3–4.CrossRefPubMedGoogle Scholar
  66. 66.
    Scott MJ, El-Hassan M, Khan AA. Myocardial infarction in a young adult following the consumption of a caffeinated energy drink. BMJ Case Rep. 2011;2011:bcr0220113854.PubMedPubMedCentralGoogle Scholar
  67. 67.
    Di Rocco JR, During A, Morelli P, Heyden M, Babcaniello TA. Atrial fibrillation in healthy adolescents after highly caffeinated beverage consumption: two case reports. J Med Case Rep. 2011;5:18–24.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Frost L, Vestergaard P. Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr. 2005;81:578–82.CrossRefPubMedGoogle Scholar
  69. 69.
    Kaoukis A, Panagopoulou V, Mojibian HR, Jacoby D. Reverse Takotsubo cardiomyopathy associated with the consumption of an energy drink. Circulation. 2012;125:1584–5.CrossRefPubMedGoogle Scholar
  70. 70.
    Wilson RE, Kado HS, Samson R, Miller AB. A case of caffeine-induced coronary artery vasospasm of a 17-year-old male. Cardiovasc Toxicol. 2012;12:175–9.CrossRefPubMedGoogle Scholar
  71. 71.
    Israelit SH, Strizevsky A, Raviv B. Case report: ST elevation myocardial infarction in a young patient after ingestion of caffeinated energy drink and ecstasy. World J Emerg Med. 2012;3:305–7.CrossRefGoogle Scholar
  72. 72.
    Benjo AM, Pineda AM, Nascimento FO, Zamora C, Lamas GA, Escolar E. Left main coronary artery acute thrombosis related to energy drink intake. Circulation. 2012;125:1447–8.CrossRefPubMedGoogle Scholar
  73. 73.
    Dufendach KA, Horner JM, Cannon BC, Ackerman MJ. Congenital type 1 long QT syndrome unmasked by a highly caffeinated energy drink. Heart Rhythm. 2012;9:285–8.CrossRefPubMedGoogle Scholar
  74. 74.
    Polat N, Ardiç I, Akkoyun M, Vuruscan E. Spontaneous coronary dissection in a healthy adolescent following consumption of caffeinated “energy drinks”. Turk Kardiyol Dern Ars. 2013;41:738–42.CrossRefPubMedGoogle Scholar
  75. 75.
    Unal S, Sensoy B, Yilmaz S, Unal GG, Suleymanoglu M, Sen F, et al. Left main coronary artery thrombosis and acute anterior myocardial infarction related to energy drink. Int J Cardiol. 2015;179:66–7.CrossRefPubMedGoogle Scholar
  76. 76.
    Solomin D, Boron SW, Watts SH. STEMI associated with overuse of energy drinks. Case Reports Emerg Med. 2015;2015:3.CrossRefGoogle Scholar
  77. 77.
    Sattari M, Sattari A, Kazory A. Energy drink consumption and cardiac complications: a case for caution. J Addict Med. 2016;10:280–2.CrossRefPubMedGoogle Scholar
  78. 78.
    Usman A, Jawaid A. Hypertension in a young boy: an energy drink effect. BMC Research notes. 2012;5:591–3.CrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Jonjev ZS, Bala G. High energy drinks may provoke aortic dissection. Coll Antropol. 2013;37(Suppl 2):227–9.PubMedGoogle Scholar
  80. 80.
    Holmgren P, Norden-Petterson L, Ahlner J. Caffeine fatalities-four case-reports. Forensic Sci Int. 2004;139:71–3.CrossRefPubMedGoogle Scholar
  81. 81.
    Rudolph T, Knudsen K. A case of fatal caffeine poisoning. Acta Anaesthesiol Scand. 2010;54(4):521–3.CrossRefPubMedGoogle Scholar
  82. 82.
    Bellet S, Horstmann E, Roman LR, DeGuzman NT, Kostis JB. Effect of caffeine on the ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. Am Heart J. 1972;84:215–27.CrossRefPubMedGoogle Scholar
  83. 83.
    Gray B, Ingles J, Media C, Driscoll T, Semsarian C. Cardiovascular effects of energy drinks in familial long QT syndrome: a randomized cross-over study. Int J Cardiol. 2017;231:150–4.CrossRefPubMedGoogle Scholar
  84. 84.
    Schwartz P, Dagradi F. Red Bull: red flag or red herring. Int J Cardiol. 2017;231:179–80.CrossRefPubMedGoogle Scholar
  85. 85.
    Shah SA, Lacey CS, Bergendahl T, Kolasa M, Riddock IC. QTc interval prolongation with high dose energy consumption in a healthy volunteer. Int J Cardiol. 2014;172:e366–37.CrossRefGoogle Scholar
  86. 86.
    Worthley MI, Prabhu A, De Sciscio P, Schultz C, Sanders P, Willoughby SR. Detrimental effects of energy drink consumption on platelet and endothelial function. Am J Med. 2010;123:184–7.CrossRefPubMedGoogle Scholar
  87. 87.
    Oteri A, Salvo F, Calapai G. Intake of energy drinks in association with alcohol beverages in a cohort of students of the school of medicine of the University of Messina. Alcohol Clin Exp Res. 2007;31:1677–80.CrossRefPubMedGoogle Scholar
  88. 88.
    Marczinski CA, Fillmore MT. Energy drinks with alcohol: what are the risks? Nutr Rev. 2014;72:98–107.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    Pennay A, Lubman DI. Alcohol and energy drinks: a pilot study exploring patterns of consumption, social contexts, benefits and harms. BMC Res Notes. 2012;5:369.CrossRefPubMedPubMedCentralGoogle Scholar
  90. 90.
    Johnson JJ, Alford C, Stewart K, Verster JC. Are energy drinks unique mixers in terms of their effects on alcohol consumption and negative alcohol-related consequences. Int J of General Med. 2018;11:15–23.CrossRefGoogle Scholar
  91. 91.
    Souza DB, Del Coso J, Casonatto J, Polito MD. Acute effects of caffeine-containing drinks on physical performance: a systematic review and meta-analysis. Eur J Nutr. 2017;56:13–27.CrossRefPubMedGoogle Scholar
  92. 92.
    Graham TE. Caffeine and exercise: metabolism, endurance and performance. Sports Med. 2001;31:785–807.CrossRefPubMedGoogle Scholar
  93. 93.
    Sengpiel V, Elind E, Bacelis J, Nilsson S, Grove J, Myhre R, et al. Caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study. BMC Med. 2013;11:42.CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Campbell B, Wilborn C, La Bounty P, Taylor L, Nelson MT, Greenwood M, et al. International Society of Sports Nutrition. Position stand: energy drinks. J Int Soc Sports Nutr. 2013;10:1–16.CrossRefPubMedPubMedCentralGoogle Scholar
  95. 95.
  96. 96.
    French Food Safety Agency (Afssa) Opinion on the assessment of risk from consumption of an energy drink (English). 2006. https://www.anses.fr/fr/system/files/NUT2006sa0236EN.pdf. Accessed 2 Dec 2006
  97. 97.
    Temple JL, Dewey AM, Briatico LN. Effects of acute caffeine administration on adolescents. Exp Clin Pharmacol. 2010;18:510–20.Google Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of CardiologyAix-Marseille UniversitéMarseilleFrance
  2. 2.Cardiology DivisionG. B. Grassi HospitalOstia LidoItaly
  3. 3.Department of CardiologyUniversità Politecnica delle MarcheAnconaItaly
  4. 4.Department of CardiologyMemorial Ankara HospitalAnkaraTurkey
  5. 5.Department of Cardiovascular Emergencies, Internal Medicine, Geriatric, School of MedicineFederico II UniversityNaplesItaly
  6. 6.Health Management, School of MedicineFederico II UniversityNaplesItaly
  7. 7.Alliance to Fight Atrial fibrillationVenice-MestreItaly
  8. 8.Humanitas Ospedale MilanoRozzanoItaly

Personalised recommendations